Head to Head Review: Lendway (NASDAQ:LDWY) & Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ:YTEN) and Lendway (NASDAQ:LDWY) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Profitability

This table compares Yield10 Bioscience and Lendway’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yield10 Bioscience	N/A	N/A	-296.08%
Lendway	N/A	-21.56%	-4.32%

Volatility and Risk

Yield10 Bioscience has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, Lendway has a beta of 1.89, meaning that its stock price is 89% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for Yield10 Bioscience and Lendway, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yield10 Bioscience	0	1	0	0	2.00
Lendway	0	0	0	0	0.00

Insider & Institutional Ownership

4.9% of Yield10 Bioscience shares are held by institutional investors. Comparatively, 6.6% of Lendway shares are held by institutional investors. 6.1% of Yield10 Bioscience shares are held by company insiders. Comparatively, 13.2% of Lendway shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Yield10 Bioscience and Lendway”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yield10 Bioscience	$60,000.00	0.02	-$14.45 million	($26.12)	0.00
Lendway	$18.80 million	0.41	$2.41 million	($1.98)	-2.20

Lendway has higher revenue and earnings than Yield10 Bioscience. Lendway is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

Summary

Lendway beats Yield10 Bioscience on 8 of the 11 factors compared between the two stocks.

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

About Lendway

Lendway, Inc. operates as a specialty agricultural and finance company focusing on making and managing its agricultural investments in the United States and internationally. It owns and operates FarmlandCredit.com, a non-bank lending business that seeks to purchase existing loans and/or originate and fund new loans domestically. The company was formerly known as Insignia Systems, Inc. and changed its name to Lendway, Inc. in August 2023. The company was incorporated in 1990 and is headquartered in Minneapolis, Minnesota.